Pictet Asset Management
AMRX icon

Pictet Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Pictet Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
611,230
+582,573
+2,033% +$7.98M 0.01% 675
2026
Q1 		$356K Hold
28,657
– – ﹤0.01% 1641
2025
Q4 		$361K Buy
28,657
+4,185
+17% +$47.9K ﹤0.01% 1613
2025
Q3 		$245K Hold
24,472
– – ﹤0.01% 1767
2025
Q2 		$198K Hold
24,472
– – ﹤0.01% 1827
2025
Q1 		$205K Buy
24,472
+3,960
+19% +$33.1K ﹤0.01% 1786
2024
Q4 		$162K Hold
20,512
– – ﹤0.01% 1896
2024
Q3 		$171K Hold
20,512
– – ﹤0.01% 1857
2024
Q2 		$130K Buy
20,512
+5,899
+40% +$37.4K ﹤0.01% 1850
2024
Q1 		$88.6K Sell
14,613
-5,435
-27% -$30.6K ﹤0.01% 1901
2023
Q4 		$122K Buy
+20,048
New +$89.3K ﹤0.01% 1848

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Pictet Asset Management's AMRX Position: Q2 2026 in Review

Pictet Asset Management increased its Amneal Pharmaceuticals (AMRX) stake by 2,033% in Q2 2026, buying an estimated $7.98M and bringing the position to 611,230 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #675.

Pictet Asset Management first reported a position in AMRX in Q4 2023 and has held it in 11 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Pictet Asset Management held 611,230 shares of Amneal Pharmaceuticals worth $10.6M as of Q2 2026.
  • Pictet Asset Management bought 582,573 Amneal Pharmaceuticals shares in Q2 2026, an estimated $7.98M.
  • Amneal Pharmaceuticals made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #675 holding.
  • Pictet Asset Management first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.